Consistent with this, our results showed also that BMAL1-KD in metastatic SW620 cells did not alter NR1D1 and CLOCK expression in contrast to our results in both primary CRC cell lines [21]. This evidence concerns the gene NR1D1 and colorectal carcinoma.